| 常用名 | 非昔硝唑 | CAS号 | 59729-37-2 |
|---|---|---|---|
| 价格 | 纯度 | 99.0% | |
| 备货期 | 10天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: Fexinidazole is a 5-nitroimidazole drug currently in clinical development for the treatment of human sleeping sickness (human African trypanosomiasis [HAT]), caused by infection with species of the protozoan parasite Trypanosoma brucei. Target: Antiparasiticin vivo: Fexinidazole shows dose-related efficacy in the T. b. rhodesiense (STIB900) acute mouse model at intraperitoneal (i.p.) doses of 20 to 50 mg/kg/day and oral (per os [p.o.]) doses of 25 to 100 mg/kg/day given on four consecutive days, with 100 mg/kg/day p.o. being 100% curative. Fexinidazole is shown to be effective in the GVR35 mouse model, which mimics the advanced and fatal stage of the disease, when parasites have disseminated into the brain. [1] 物理化学性质: CAS号:59729-37-2 常用中文名:非昔硝唑 常用英文名:Fexinidazole 分子式:C12H13N3O3S 分子量:279.315 密度:1.3±0.1 g/cm3 沸点:511.3±40.0 °C at 760 mmHg 熔点:N/A 闪点:263.0±27.3 °C 储存条件:2-8℃ |